Your browser doesn't support javascript.
loading
Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis.
Snyder, Alexandra; Nathanson, Tavi; Funt, Samuel A; Ahuja, Arun; Buros Novik, Jacqueline; Hellmann, Matthew D; Chang, Eliza; Aksoy, Bulent Arman; Al-Ahmadie, Hikmat; Yusko, Erik; Vignali, Marissa; Benzeno, Sharon; Boyd, Mariel; Moran, Meredith; Iyer, Gopa; Robins, Harlan S; Mardis, Elaine R; Merghoub, Taha; Hammerbacher, Jeff; Rosenberg, Jonathan E; Bajorin, Dean F.
Affiliation
  • Snyder A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
  • Nathanson T; Department of Medicine, Weill Cornell Medical College, New York, New York, United States of America.
  • Funt SA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Ahuja A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
  • Buros Novik J; Department of Medicine, Weill Cornell Medical College, New York, New York, United States of America.
  • Hellmann MD; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Chang E; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Aksoy BA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
  • Al-Ahmadie H; Department of Medicine, Weill Cornell Medical College, New York, New York, United States of America.
  • Yusko E; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Vignali M; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Benzeno S; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
  • Boyd M; Adaptive Biotechnologies, Seattle, Washington, United States of America.
  • Moran M; Adaptive Biotechnologies, Seattle, Washington, United States of America.
  • Iyer G; Adaptive Biotechnologies, Seattle, Washington, United States of America.
  • Robins HS; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
  • Mardis ER; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
  • Merghoub T; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
  • Hammerbacher J; Department of Medicine, Weill Cornell Medical College, New York, New York, United States of America.
  • Rosenberg JE; Adaptive Biotechnologies, Seattle, Washington, United States of America.
  • Bajorin DF; Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
PLoS Med ; 14(5): e1002309, 2017 05.
Article in En | MEDLINE | ID: mdl-28552987
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma / Urologic Neoplasms / B7-H1 Antigen / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2017 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma / Urologic Neoplasms / B7-H1 Antigen / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2017 Type: Article